Methicillin‐resistant Staphylococcus aureous contamination of surgical wounds: Are there effective interventions?

Methicillin‐resistant Staphylococcus aureous contamination of surgical wounds: Are there effective interventions?

Surgical Site Infections (SSIs) in the US SSIs are the most common and most costly type of hospital‐acquired infection, occurring in an estimated 160,000 to 300,000 patients in the US each year.[1] SSIs increase morbidity and mortality, result in longer hospital stays and substantially increased cost of care. In fact, it has been demonstrated that…

Blog Title: The New ReliaTect Instructional Video

CGI for HCP Product Education: The New ReliaTect Instructional Video

Instructional videos are a very important tool often used to educate healthcare providers on safe use of medical devices.  They provide a great platform to deliver detailed and easy-to-digest instructions whether the device is of a more complicated nature or not.  Video can be a great complement to printed tools, but when is the last…

Introducing ReliaTect Post-Op Dressing

Eloquest Healthcare recently introduced ReliaTect™ Post-Op Dressing featuring BeneHold™ CHG Adhesive Technology. ReliaTect is the post-op dressing that integrates the antimicrobial properties of chlorhexidine gluconate (CHG), the practicality of absorbency, and the convenience of transparency. THE ANTIMICROBIAL POST-OP DRESSING WITH ABSORB&SEE ReliaTect has convenience features for staff1: ABSORBS EXUDATE to protect against dehydration and facilitate…

Antimicrobial Dressings: The Silver Mystique

As mentioned in our last posting, SSIs are the most common and costly of all hospital-acquired infections in the US.1 If you happened to have missed it, read it here. Accordingly, efforts to reduce SSI rates have led to the development of post-op dressings with antimicrobial agents impregnated within the dressing. These dressing inhibit the…

SSIs and Post-Op Dressings: What’s Missing?

You might remember from our previous blogs that certain measures, like surgical site infections (SSIs) are penalized in multiple programs of the Affordable Care Act—in the Value-Based Purchasing Program as well as the Hospital-Acquired Conditions Reduction Program. View Blog #2 and Blog #3 here. SSIs are the most common and costly of all hospital-acquired infections…